MK-7

product on market Capsule Bio-Tech Pharmacal 🟢 Safety: 100/100
Brand: Bio-Tech Pharmacal
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

150 mcg (125% DV)
✅ 1.2× RDA — within safe limits 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.15mg

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Methylcellulose (vegetable) Capsules Dicalcium Phosphate

Label Claims — Verification

❓ Nutrient
❓ All Other
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Kosher Halal Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: One capsule per day or as directed. Individuals taking blood-thinning medications should consult a healthcare professional.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Safety sealed for your protection.

Individuals taking blood-thinning medications should consult a healthcare professional.

🧪 Formulation Notes

Contains No: Dairy, egg, fish, shellfish, nuts, wheat, gluten, soy, sugar, yeast, artificial preservatives or colors.

Kosher and Halal certified.

Kosher and Halal certified.

Gluten free Non GMO

Vitamin K2

cGMP Current Good Manufacturing Practice

Additional Information

Store tightly closed in a cool, dry place.

Energy = Health

EarthKosher

cGMP Current Good Manufacturing Practice

PNR Over 100 Partners in Research

ISWA Halal

Made in the USA

Product Details

UPC / SKU 7 05105 10780 6
DSLD Entry Date 2020-04-23
Product Type Vitamin
Form Capsule
Brand Bio-Tech Pharmacal
DSLD ID 217281
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI
View all evidence for Vitamin K →

Compare Similar Products

Vitamin D Synergy with Vitamin K1 Designs for Health 100
Vitamin D Synergy with Vitamin K1 Designs for Health 100
Natural Vitamin K2 45 mcg Doctor's Best 100
K 100 mcg Thompson 100
Vitamin K2 300 mcg MK-7 Innerzyme 100
View all Vitamin K products →
Vitamin K research & evidence Best Vitamin K rankings All Vitamin K products More from Bio-Tech Pharmacal View on NIH DSLD →